Menaquinone-4 (Vitamin K2)
(Synonyms: 四烯甲萘醌,Vitamin K2(MK-4); Menaquinone K4) 目录号 : GC30258
Menaquinone-4 (Vitamin K2)是一种含有四个异戊二烯单元的维生素K2，属于萘醌家族。
Cas No.:863-61-6
Sample solution is provided at 25 µL, 10mM.
_1-3.$$$39978408@51.jpg');)
_1-9.$$$38538795@65.jpg');)
_1-9.$$$39112701@51.jpg');)
_1-7.$$$37316672@70.jpg');)
_366-372.$$$36198801@70.jpg');)
.$$$38565142@65.jpg');)
_1867-1883.$$$33248023@67.jpg');)
_eads6055.$$$39977546@45.jpg');)
_eadm9805.$$$40080571@45.jpg');)
_eadj3020.$$$39666821@45.jpg');)
_1-20.$$$39757301@28.jpg');)
_1-24.$$$38898113@28.jpg');)
_273-287.$$$36806353@46.jpg');)
_1-16.$$$37156877@44.jpg');)
_1-19.$$$37460805@44.jpg');)
_1291-1307.$$$34518654@46.jpg');)
Menaquinone-4 (Vitamin K2) is a vitamin K2 containing four isoprene units and belongs to the naphthoquinone family [1]. Menaquinone-4 is mainly formed through the conversion of intracellular vitamin K1 and accumulates in various tissues, playing an important role in protecting the heart and brain and building strong bones [2]. Menaquinone-4 can be used as a hemostatic agent and is used to treat osteoporosis [3].
In vitro, Menaquinone-4 (0, 1.0, 5.0 and 10.0μM; 0, 3, 7 and 11 days) increased the ALP activity in Caco-2 cells in a time-dependent manner, and the expression of TNSALP mRNA also increased [4]. In LPS-induced MG6 cells, Menaquinone-4 (0-10μM; 24h) dose-dependently inhibited the upregulation of inflammatory cytokines at the mRNA level, significantly reduced the phosphorylation of p65, but did not affect TAK1 and IKKα/β. Menaquinone-4 could inhibit the nuclear translocation of NF-κB in LPS-induced MG6 cells [5].
In vivo, Menaquinone-4 (200mg/kg diet; 12 weeks) increased the serum osteocalcin level in obese mice induced by a high-fat diet and increased the bone density of mice [6]. Menaquinone-4 (40mg/kg/day; i.p.; single injection) significantly reduced the content of iron metabolism genes in mice with acute liver injury induced by CCl4, and the mRNA expression levels of FPN and HJV significantly increased, while the mRNA expression level of TFR1 significantly decreased [7].
References:
[1] Sogabe N, Maruyama R, Hosoi T, et al. Enhancement effects of vitamin K1 (phylloquinone) or vitamin K2 (menaquinone-4) on intestinal alkaline phosphatase activity in rats[J]. Journal of nutritional science and vitaminology, 2007, 53(3): 219-224.
[2] Okano T, Shimomura Y, Yamane M, et al. Conversion of phylloquinone (Vitamin K1) into menaquinone-4 (Vitamin K2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice[J]. Journal of Biological Chemistry, 2008, 283(17): 11270-11279.
[3] Okamoto H, Shidara K, Hoshi D, et al. Anti‐arthritis effects of vitamin K2 (menaquinone‐4)− a new potential therapeutic strategy for rheumatoid arthritis[J]. The FEBS journal, 2007, 274(17): 4588-4594. [4] Noda S, et al. Menaquinone-4 (vitamin K2) up-regulates expression of human intestinal alkaline phosphatase in Caco-2 cells. Nutr Res. 2016 Nov;36(11):1269-1276.
[5] Saputra W D, Aoyama N, Komai M, et al. Menaquinone-4 suppresses lipopolysaccharide-induced inflammation in MG6 mouse microglia-derived cells by inhibiting the NF-κB signaling pathway[J]. International journal of molecular sciences, 2019, 20(9): 2317.
[6] Kim M, et al. Vitamin K1 (phylloquinone) and K2 (menaquinone-4) supplementation improves bone formation in a high-fat diet-induced obese mice. J Clin Biochem Nutr. 2013 Sep;53(2):108-13.
[7] YE L, ZHAO F, HUANG Q, et al. Menaquinone-4 exerts a protective effect against carbon tetrachloride-induced acute liver injury in mice by alleviating ferroptosis[J]. Journal of Clinical Hepatology, 2024: 121-128.
Menaquinone-4 (Vitamin K2)是一种含有四个异戊二烯单元的维生素K2，属于萘醌家族 [1]。 Menaquinone-4主要通过体内维生素K1的转化形成，并在各种组织中积累，在保护心脏和大脑、构建强壮的骨骼过程中发挥重要作用 [2]。Menaquinone-4可用作一种止血剂并且可以治疗骨质疏松 [3]。
在体外，Menaquinone-4（0, 1.0, 5.0和10.0μM; 0, 3, 7和11 days）以时间依赖性增加了Caco-2细胞中的ALP活性，同时TNSALP mRNA表达增加 [4]。在LPS诱导的 MG 6细胞中，Menaquinone-4（0-10µM; 24h）在mRNA水平上剂量依赖性地抑制炎性细胞因子的上调，显著降低p65的磷酸化，但不影响TAK 1和IKKα/β。Menaquinone-4可抑制LPS诱导的MG 6细胞NF-κB核转位 [5]。
在体内，Menaquinone-4（200mg/kg饮食; 12周）提高了高脂饮食诱导的肥胖小鼠的血清骨钙素水平，同时增加了小鼠的骨密度 [6]。Menaquinone-4（40mg/kg/day; i.p.; 单次注射）显著降低CCl4诱导的急性肝损伤小鼠的铁代谢基因含量，FPN和HJV的mRNA表达水平显著增加，TFR 1 mRNA表达水平显著降低 [7]。
| Cell experiment [1]: | |
Cell lines | Caco-2 cells |
Preparation Method | Caco-2 cells were grown at 37°C in 5% CO2 in Dulbecco modified Eagle medium containing 10% fetal bovine serum, 1% nonessential amino acids, and antibiotics (100U/mL penicillin, 50μg/mL streptomycin, and 100μg/mL of neomycin). Menaquinone-4 was kindly supplied by Eisai Co. MK-4 was dissolved in ethanol and stored at -20°C in the dark until use. Caco-2 cells were plated at a density of 2-5 × 104 cells/cm2 onto a 35-mm2. Cells were incubated for 2 to 3 days until 60%-70% confluency, and desired concentrations of Menaquinone-4 (0, 1.0, 5.0 and 10.0μM) were added. The final concentration of the vehicle was 0.1% of the culture medium, and the culture medium was changed twice a week. Cells were assayed on days 0, 3, 7 and 11 after the addition of Menaquinone-4. |
Reaction Conditions | 0, 1.0, 5.0 and 10.0μM; 0, 3, 7 and 11 days |
Applications | Menaquinone-4 increased the ALP activity in Caco-2 cells in a time-dependent manner, and at the same time, the expression of TNSALP mRNA also increased. |
| Animal experiment [2]: | |
Animal models | C57BL/6J mice |
Preparation Method | Forty-two male, 4-week-old C57BL/6J mice were purchased from Central Lab Animal Inc., Korea. For environmental adaptation, the animals had 1 week of circulation, and then were provided with the experimental diet after being randomly divided into 6 groups (7 animals in each group; randomized block design). The AIN-93G diets consisted of a normal diet (N), normal diet + vitamin K1 (N-K1), normal diet + Menaquinone-4, 45% high-fat diet (HF), 45% high-fat diet + vitamin K1 (HF-K1), and a 45% high-fat diet + Menaquinone-4. The vitamin K1 and Menaquinone-4 contents were 200mg/1,000g, and the diet was provided in pellet form. The details are listed in Table 1. Food intake amount was measured every other day. Body weight was measured once a week, and the food efficiency ratio (FER) was calculated by dividing the increased body weight from day 1 to the final day by the food intake amount during the experiment period. For fat amount measurement, the epididymal fat, perirenal fat, and retroperitoneal fat were extracted from dead animal subjects, were washed with 0.9% NaCl, dried by filter paper, and then were weighed. |
Dosage form | 200mg/kg of diet for 12 weeks |
Applications | Menaquinone-4 increased the serum osteocalcin levels in obese mice induced by a high-fat diet, and also enhanced the bone density of the mice. |
References: | |
| Cas No. | 863-61-6 | SDF | |
| 别名 | 四烯甲萘醌,Vitamin K2(MK-4); Menaquinone K4 | ||
| Canonical SMILES | O=C1C(C)=C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)\C)C(C2=C1C=CC=C2)=O | ||
| 分子式 | C31H40O2 | 分子量 | 444.65 |
| 溶解度 | DMSO : 20.83 mg/mL (46.85 mM);Water : < 0.1 mg/mL (insoluble) | 储存条件 | 4°C, protect from light |
| General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。 储备液的保存方式和期限：-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。 为了提高溶解度，请将管子加热至37℃，然后在超声波浴中震荡一段时间。 |
||
| Shipping Condition | 评估样品解决方案：配备蓝冰进行发货。所有其他可用尺寸：配备RT，或根据请求配备蓝冰。 | ||
| 制备储备液 | |||
 |
1 mg | 5 mg | 10 mg |
| 1 mM | 2.249 mL | 11.2448 mL | 22.4896 mL |
| 5 mM | 0.4498 mL | 2.249 mL | 4.4979 mL |
| 10 mM | 0.2249 mL | 1.1245 mL | 2.249 mL |
| 第一步：请输入基本实验信息（考虑到实验过程中的损耗，建议多配一只动物的药量） | ||||||||||
| 给药剂量 | mg/kg |  |
动物平均体重 | g | |
每只动物给药体积 | ul | |
动物数量 | 只 |
| 第二步：请输入动物体内配方组成（配方适用于不溶于水的药物；不同批次药物配方比例不同，请联系GLPBIO为您提供正确的澄清溶液配方） | ||||||||||
| % DMSO % % Tween 80 % saline | ||||||||||
| 计算重置 | ||||||||||
计算结果:
工作液浓度： mg/ml；
DMSO母液配制方法： mg 药物溶于 μL DMSO溶液（母液浓度 mg/mL，
体内配方配制方法：取 μL DMSO母液，加入 μL PEG300，混匀澄清后加入μL Tween 80，混匀澄清后加入 μL saline，混匀澄清。
1. 首先保证母液是澄清的；
2.
一定要按照顺序依次将溶剂加入，进行下一步操作之前必须保证上一步操作得到的是澄清的溶液，可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet